Abstract
One of the theories of the pathogenesis of Alzheimer’s disease (AD) is that blood-brain barrier (BBB) dysfunction is the primary event (for review see 1,2). Also in aging, BBB dysfunction has been suggested (for review see 2). AD is associated with aging, i.e., it is more frequent in higher age. Many other diseases are in the same way associated with aging and thus expected to occur together with AD quite frequently. Some of these age-associated diseases, for instance hypertension, diabetes mellitus and various manifestations of arteriosclerosis have an important effect on the cerebral vasculature and the BBB function (2,3). Thus, when examining the BBB function in aging and AD, the coexistence of other diseases suspected of interfering with the BBB function should be taken ino account.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Hardy J, Mann D, Wester P, Winblad B. An integrative hypothesis concerning the pathogenesis and progression of Alzheimer’s disease. Neurobiol.Aging 7: 489–502, 1986.
Mooradian A. Review. Effect of aging on the blood-brain barrier. Neurobiol.Aging 9: 31–39, 1988.
Rapport S. Blood-brain barrier in physiology and medicine. New York: Raven Press, 129–152, 1976.
McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s disease. Neurology 34: 939–944, 1984.
Blennow K, Wallin A, Gottfries CG. Presence of parieto-temporal symptomatology distinguishes early and late onset Alzheimer’s disease. Submitted.
Sjögren T, Sjögren H, Lindgren A. Morbus Alzheimer and morbus Pick: A genetic, clinical and patho-anatomical study. Acta Psych.Neurol. Scand. (Suppl. 82 ): 66–115, 1952.
Elovaara I., Icen A., Palo J, Erkinjuntti T, CSF in Alzheimer’s disease, studies on blood-brain barrier function and intrathecal protein synthesis. J. Neurol. Sci. 70:73–80, 1985.
Elovaara I, Seppälä I, Palo J, Sulkava R, Erkinjuntti T. Oligoclonal inanunoglobulin bands in cerebrospinal fluid of patients with Alzheimer’s disease and vascular dementia. Acta Neurol.Scand.77:397-401, 1988.
Kay A, May C, Papadopoulos N et al. CSF and serum concentration of albumin and IgG in Alzheimer’s disease. Neurobiol.Aging 8: 21–25, 1987.
Leonardi A, Gandolfo C, Caponetto C, Arata L, Vecchia R, The integrity of the blood-brain barrier in Alzheimer’s type and multiinfarct dementia evaluated by the study of albumin and IgG in serum and cerebrospinal fluid. J. Neurol. Sci. 67:253–261, 1985.
Erkinjuntti T. Differential diagnosis between Alzheimer’s disease and vascular dementia: evaluation of common clinical methods. Acta Neurol. Scand. 76:422–433, 1987.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1990 Plenum Press, New York
About this chapter
Cite this chapter
Blennow, K., Wallin, A., Fredman, P., Karlsson, I., Gottfries, C.G., Svennerholm, L. (1990). Blood-Brain Barrier Disturbance in Patients with Alzheimer’s Disease is Related to Vascular Factors. In: Nagatsu, T., Fisher, A., Yoshida, M. (eds) Basic, Clinical, and Therapeutic Aspects of Alzheimer’s and Parkinson’s Diseases. Advances in Behavioral Biology, vol 38A. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-5844-2_39
Download citation
DOI: https://doi.org/10.1007/978-1-4684-5844-2_39
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-5846-6
Online ISBN: 978-1-4684-5844-2
eBook Packages: Springer Book Archive